[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100569276":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":35,"locations":41,"responsibleParty":93,"collaborators":26,"id":95,"slug":26,"hasResults":96,"nctId":97,"briefTitle":98,"officialTitle":99,"acronym":100,"eligibilityCriteria":101,"healthyVolunteers":96,"sex":102,"minAge":103,"maxAge":26,"enrollmentInfo":104,"targetDuration":26,"studyType":107,"phases":108,"briefSummary":110,"conditions":111,"keywords":115,"overallStatus":44,"whyStopped":26,"lastUpdateSubmitDate":118,"lastUpdatePostDateStruct":119,"startDateStruct":122,"completionDateStruct":124,"leadSponsor":126,"locationsCount":127},{"fullName":5,"class":6},"Odense University Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Ultra-low strut thickness everolimus-eluting biodegradable polymer Evermine50 stent","EXPERIMENTAL","Percutaneous coronary interventin with Ultra-low strut thickness everolimus-eluting biodegradable polymer Evermine50 stent",[13],"Device: Ultra-low strut thickness everolimus-eluting biodegradable polymer Evermine50 stent(s)",{"label":15,"type":16,"description":17,"interventionNames":18},"Everolimus-eluting stents (durable polymer everolimus-eluting Xience or Promus stent)","ACTIVE_COMPARATOR","Percutaneous coronary intervention with Everolimus-eluting stents (durable polymer everolimus-eluting Xience or Promus stent)",[19],"Device: PCI with Everolimus-eluting stents (durable polymer everolimus-eluting Xience or Promus stent(s))",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DEVICE","Ultra-low strut thickness everolimus-eluting biodegradable polymer Evermine50 stent(s)","Percutaneous coronary intervention with Ultra-low strut thickness everolimus-eluting biodegradable polymer Evermine50 stent(s)",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"PCI with Everolimus-eluting stents (durable polymer everolimus-eluting Xience or Promus stent(s))","Percutaneous coronary intervention with Everolimus-eluting stents (durable polymer everolimus-eluting Xience or Promus stent(s))",[15],[32],{"name":33,"affiliation":5,"role":34},"Lisette O Jensen","PRINCIPAL_INVESTIGATOR",[36],{"name":37,"role":38,"phone":39,"phoneExt":26,"email":40},"Lisette O Jensen, MD","CONTACT","+4565412690","lisette.okkels.jensen@rsyd.dk",[42,62,79],{"facility":43,"status":44,"city":45,"state":26,"zip":46,"country":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"Aalborg University Hospital","RECRUITING","Aalborg","9000","Denmark",{"type":49,"coordinates":50},"Point",[51,52],9.9187,57.048,{"lat":52,"lon":51},[55,59,60],{"name":56,"role":38,"phone":57,"phoneExt":26,"email":58},"Ashkan Eftekhari, MD","+4597660000","asef@rn.dk",{"name":56,"role":38,"phone":26,"phoneExt":26,"email":26},{"name":61,"role":38,"phone":26,"phoneExt":26,"email":26},"Phillip Freeman, MD",{"facility":63,"status":44,"city":64,"state":26,"zip":65,"country":47,"cosmosGeoPoint":66,"geoPoint":70,"contacts":71},"Aarhus University Hospital","Aarhus","8200",{"type":49,"coordinates":67},[68,69],10.21076,56.15674,{"lat":69,"lon":68},[72,76,77],{"name":73,"role":38,"phone":74,"phoneExt":26,"email":75},"Evald H Christiansen, MD","+4578450000","evald.christiansen@rm.dk",{"name":73,"role":38,"phone":26,"phoneExt":26,"email":26},{"name":78,"role":38,"phone":26,"phoneExt":26,"email":26},"Lars Jakobsen, MD",{"facility":5,"status":44,"city":80,"state":26,"zip":81,"country":47,"cosmosGeoPoint":82,"geoPoint":86,"contacts":87},"Odense","5000",{"type":49,"coordinates":83},[84,85],10.38831,55.39594,{"lat":85,"lon":84},[88,90,91],{"name":37,"role":38,"phone":89,"phoneExt":26,"email":40},"+4565412620",{"name":37,"role":38,"phone":26,"phoneExt":26,"email":26},{"name":92,"role":38,"phone":26,"phoneExt":26,"email":26},"Jens F Lassen, MD",{"type":94,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100569276",false,"NCT06692140","Comparison of an Ultra-low Strut Thickness Everolimus-eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus-eluting Stents in Patients Treated with Percutaneous Coronary Intervention","Randomized Comparison of an Ultra-low Strut Thickness Everolimus-eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus-eluting Stents in Patients Treated with Percutaneous Coronary Intervention in an All Comer Population (The SORT OUT XII Trial)","SORT OUT XII","Inclusion Criteria:\n\n* All patients aged ≥18 years who are eligible for treatment with one or several drug-eluting coronary stents\n\nExclusion Criteria:\n\n* Age \\\u003C 18 years\n* Not able to consent to study participating (eg. intubated patients)\n* Unstable circuit or in cardiogenic shock and therefore not able to understand the information and purpose of the study\n* Do not speak Danish\n* Already included in the SORT OUT XII study\n* Life expectancy \\\u003C1 year\n* Allergic to study related treatment","ALL","18 Years",{"count":105,"type":106},3150,"ESTIMATED","INTERVENTIONAL",[109],"NA","The objective of this randomized study is to compare the safety and efficacy of the ultra-low strut thickness everolimus-eluting biodegradable polymer Evermine50 stent to the everolimus-eluting family stents (durable polymer everolimus-eluting Xience or Promus stents) in a population-based setting with coronary artery stenosis treated with percutaneous coronary intervention",[112,113,114],"Ischemia, Myocardial","Coronary Artery Disease","Percutaneous Coronary Intervention (PCI)",[116,117],"Drug-eluting stent","outcome","2024-12-04",{"date":120,"type":121},"2024-12-09","ACTUAL",{"date":123,"type":121},"2024-11-16",{"date":125,"type":106},"2032-07-01",{"name":5,"class":6},3]